中性粒细胞百分比与白蛋白比值对急性ST段抬高型心肌梗死患者预后的预测价值分析

张芹; 程毅松; 贾禹; 李东泽; 邹利群; 高永莉; 叶磊; 万智

doi:10.13201/j.issn.1009-5918.2020.05.004

中性粒细胞百分比与白蛋白比值对急性ST段抬高型心肌梗死患者预后的预测价值分析

- 四川大学华西医院急诊科四川大学灾难医学中心四川大学华西护理学院急救与创伤护理学教研室(成都, 610041)
基金项目:
四川省科学技术项目(No:20ZDYF2813、2019JDRC0105、2017SZ0190)

四川大学华西医院学科卓越发展1·3·5工程临床研究孵化项目(No:2018HXFH027)

详细信息

通讯作者: 万智,E-mail:303680215@qq.com

中图分类号: R542.22

收稿日期: 2020-03-09

Prognostic value of neutrophil percentage-albumin ratio in patients with acute ST-segment elevation myocardial infarction

- Department of Emergency, West China Hospital of Sichuan University, Disaster Medical Cente of Sichuan University, Emergency and Trauma Nursing of West China Nursing College, Chengdu, 610041, China

More Information

Corresponding author: WAN Zhi, E-mail: 303680215@qq.com

Received Date: 09 March 2020

摘要

摘要: 目的:探讨中性粒细胞百分比与白蛋白比值(NPAR)对急性ST段抬高型心肌梗死(STEMI)患者的预后预测价值。方法:回顾性分析2016-07-2017-11期间我院急诊科收治的476例STEMI患者的临床资料、实验室检查以及预后情况。根据STEMI患者入院时的NPAR三分位间距,分为A组(159例)、B组(159例)、C组(158例),采用多因素Cox回归分析STEMI患者全因死亡的独立风险因子。结果:C组比A组和B组具有更高的住院病死率(13.3%vs.3.8%vs.1.3%,P<0.01)和远期病死率(22.8%vs.5.0%vs.7.5%,P<0.01),差异均有统计学意义。Kaplan-Meier生存曲线分析显示C组累计生存率低于A组和B组(77.2%vs.95.0%vs.92.5%,P<0.01)。多因素COX回归分析显示,入院时NPAR是STEMI患者全因死亡的独立危险因素[(A vs.B)HR=4.595,95%CI:1.126~18.753,P=0.034;(A vs.C)HR=7.292,95%CI:1.926~27.610,P=0.003]。结论:在急诊早期,NPAR是预测STEMI患者死亡风险的有效工具,有助于指导临床决策。
- 急性ST段抬高型心肌梗死 /
- 中性粒细胞百分比 /
- 白蛋白 /
- 预后
Abstract: Objective: To investigate the prognostic value of neutrophil percentage-albumin ratio(NPAR) in patients with acute ST segment elevation myocardial infarction(STEMI). Method: The clinical data, laboratory examination and prognosis of 476 STEMI patients admitted to the emergency department of West China Hospital from July 2016 to November 2017 were analyzed retrospectively. According to the triad interval of NPAR at admission, STEMI patients were divided into group A(n=159), group B(n=159) and group C(n=158). The independent risk factors of all-cause death in STEMI patients were analyzed by multivariate Cox regression. Result: Group C had higher in-hospital mortality(13.3% vs. 3.8% vs. 1.3%, P<0.01) and long-term mortality(22.8% vs. 5.0% vs. 7.5%, P<0.01) than group A and group B. Kaplan Meier survival curve analysis showed that the cumulative survival rate of group C was lower than that of group A and group B(77.2% vs. 95.0% vs. 92.5%, P<0.01). Multivariate Cox regression analysis showed that NPAR was an independent risk factor for all-cause death of STEMI patients[(A vs. B) HR=4.595, 95%CI: 1.126-18.753, P=0.034;(A vs. C) HR=7.292, 95%CI: 1.926-27.610, P=0.003].Conclusion: NPAR is an useful tool to predict the risk of death for STEMI patients, which is helpful to guide clinical decision-making in the early stage at emergency.
- acute ST-segment elevation myocardial infarction /
- neutrophil percentage /
- albumin /
- prognosis

HTML全文

参考文献(18)

[1]	黄震华.急性ST段抬高型心肌梗死溶栓治疗后经皮冠状动脉介入治疗的必要性和时机[J].中国新药与临床杂志,2016,(1):18-23.
[2]	Townsend N,Wilson L,Bhatnagar P,et al.Cardiovascular disease in Europe 2016:An epide miological update[J].Eur Heart J,2016,37(42):3182-3183.
[3]	Kristensen SD,Laut KG,Fajadet J,et al.Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:Current status in 37 ESC countries[J].Eur Heart J,2014,35(29):1957-1970.
[4]	Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.
[5]	Benjamin EJ,Muntner P,Alonso A,et al.Heart Disease and Stroke Statistics-2019 Update:A Report From the American Heart Association[J].Circulation,2019,139(10):e56-e528.
[6]	Shah AD,Denaxas S,Nicholas O,et al.Neutrophil counts and initial presentation of 12 cardiovascular diseases:A CALIBER Cohort Study[J].J Am Coll Cardiol,2017,69(9):1160-1169.
[7]	Fiarresga AJ,Ferreira RC,Feliciano J,et al.Prognostic value of neutrophil response in the era of acute myocardial infarction mechanical reperfusion[J].Rev Port Cardiol,2004,23(11):1387-1396.
[8]	Gonzalez-Pacheco H,Amezcua-Guerra LM,Sandoval J,et al.Prognostic implications of serum albumin levels in patients with acute coronary syndromes[J].Am J Cardiol,2017,119(7):951-958.
[9]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会.2015年急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.
[10]	Rasoul S,Ottervanger JP,de Boer MJ,et al.Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction[J].Coron Artery Dis,2009,20(6):415-421.
[11]	Marino F,Maresca AM,Castidioni L,et al.Simvastatin downregulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients[J].BMc cardiovasc Dis,2014,14(1):37.
[12]	Guast L,Madno F,Cosentino M,et al.Prolonged statin-associated reduction in neutrophil reactive oygen species and angiotensin Ⅱ type 1.recptor expression:l-year follow-up[J].Eur Heart J,2008,29(9):1118-1126.
[13]	Men M,Zhang L,Li T,et al.Prognostic Value of the Percentage of Neutrophils on Admission in Patients with ST-elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention[J].Arch Med Res,2015,46(4):274-279.
[14]	Oduncu V,Erkol A,Karabay CY,et al.The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention[J].Coron Artery Dis,2013,24(2):88-94.
[15]	Gonzalez-Pacheco H,Amezcua-Guerra LM,Sandoval J,et al.Prognostic implications of serum albumin levels in patients with acute coronary syndromes[J].Am J Cardiol,2017,119(7):951-958.
[16]	Chien SC,Chen CY,Lin CF,et al.Critical appraisal of the role of serum albumin in cardiovascular disease[J].Biomark Res,2017,5(1):31.
[17]	Lam FW,Cruz MA,Leung HC,et al.Histone induced platelet aggregation is inhibited by normal albumin[J].Thromb Res,2013,132(1):69-76.
[18]	Paar M,Rossmann C,Nusshold C,et al.Anticoagulant action of low,physiologic,and high albumin levels in whole blood[J].PLoS One,2017,12(8):e0182997.